PIL Submitted in Calcutta High Court Demanding CBI Investigation into Woman's Death Post Childbirth
Click to start listening
Kolkata, Jan 13 (NationPress) A Public Interest Litigation (PIL) has been submitted in the Calcutta High Court, requesting a thorough investigation by the Central Bureau of Investigation (CBI) concerning the demise of a young woman, two days post childbirth, at Midnapore Medical College on Friday.
Additionally, four other women who underwent C-section deliveries are in critical condition, with three of them transferred to the esteemed SSKM Hospital in Kolkata.
The petitioner, Vijay Kumar Singhal, expressed in the PIL that he lacks confidence in the police and the health department officials for an unbiased investigation, as the death of Mamoni Ruidas highlights significant flaws in the healthcare system and quality control.
Singhal remarked, "This incident raises significant concerns regarding the safety of public healthcare, systemic corruption, and a lack of accountability."
Although the precise cause of Mamoni’s death and the kidney and liver damage experienced by the others remains undetermined, allegations, including those from some doctors, suggest that substandard Ringer's Lactate was administered.
Ringer's Lactate is typically given intravenously to restore fluid loss following C-sections and other surgical procedures.
In his PIL, Singhal, who works as a chartered accountant, has accused both the administration and the pharmaceutical company responsible for supplying the intravenous drip. He referenced media reports claiming that the same company provided Ringer's Lactate to the Karnataka health department, which was associated with the deaths of four women in that state in 2024.
The Karnataka government has since blacklisted the company, and a criminal case has been initiated against it, according to Singhal.
He further noted that the Karnataka government sent a letter to the Drugs Controller General of India to investigate the Standard Quality (SQ) certification that the company received from the Central Drugs Laboratory in Kolkata. Consequently, the company was instructed to cease operations until "deficiencies were rectified." Following this, the West Bengal government also prohibited the use of Ringer's Lactate supplied by this company, yet this tragedy occurred regardless.
